CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 25 of 58 entries

View as:

Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream)

Phase: N/A Priority: Normal

NCT ID: NCT01455597 Org: User:

Start: 10/20/11 End: 12/03/12 Due: 12/03/13

Asacol Acute Diverticulitis(DIVA)Study

Phase: N/A Priority: Normal

NCT ID: NCT00554099 Org: User:

Start: 11/30/07 End: 03/31/10 Due: 03/31/11

Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido

Phase: N/A Priority: Normal

NCT ID: NCT00349791 Org: User:

Start: 06/30/02 End: 10/31/03 Due: 10/31/04

Effect of Udenafil on Spermatogenesis

Phase: N/A Priority: Normal

NCT ID: NCT01230541 Org: User:

Start: 09/30/10 End: 11/30/11 Due: 11/30/12

Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch

Phase: N/A Priority: Normal

NCT ID: NCT00791856 Org: User:

Start: 07/31/07 End: 05/31/08 Due: 05/31/09

Study Assessing Dosing Time and Calcium and Vitamin D on the Relative BA of 35 mg DR Risedronate Dosed With Food

Phase: N/A Priority: Normal

NCT ID: NCT00868907 Org: User:

Start: 03/31/09 End: 04/30/09 Due: 04/30/10

A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor Overactivity

Phase: N/A Priority: Normal

NCT ID: NCT00712322 Org: User:

Start: 10/07/08 End: 05/23/13 Due: 05/23/14

Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women

Phase: N/A Priority: Normal

NCT ID: NCT01816139 Org: User:

Start: 01/31/13 End: 11/19/13 Due: 11/19/14

Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia

Phase: N/A Priority: Normal

NCT ID: NCT01845649 Org: User:

Start: 04/12/13 End: 11/20/13 Due: 11/20/14

A Study to Assess the Bioequivalence of Different Formulations of Risedronate in Healthy Male and Female Subjects

Phase: N/A Priority: Normal

NCT ID: NCT00846196 Org: User:

Start: 01/31/09 End: 05/31/09 Due: 05/31/10

Fecal Biomarker Study for Patients With Ulcerative Colitis

Phase: N/A Priority: Normal

NCT ID: NCT00780507 Org: User:

Start: 08/31/07 End: 07/31/09 Due: 07/31/10

Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate

Phase: N/A Priority: Normal

NCT ID: NCT00778154 Org: User:

Start: 01/31/04 End: 12/31/06 Due: 12/31/07

Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate

Phase: N/A Priority: Normal

NCT ID: NCT00635609 Org: User:

Start: 03/31/08 End: 09/30/08 Due: 09/30/09

Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis

Phase: N/A Priority: Normal

NCT ID: NCT01004185 Org: User:

Start: 10/31/09 End: 03/31/11 Due: 03/31/12

A Study of Monthly Risedronate for Osteoporosis

Phase: N/A Priority: Normal

NCT ID: NCT00247273 Org: User:

Start: 10/31/05 End: 04/30/08 Due: 04/30/09

Study of Safety and Efficacy of an Oral Contraceptive

Phase: N/A Priority: Normal

NCT ID: NCT00391807 Org: User:

Start: 11/30/06 End: 09/30/08 Due: 09/30/09

Assess the Influence of a High-fat Meal on the Relative Bioavailability Of Two Formulations of Risedronate

Phase: N/A Priority: Normal

NCT ID: NCT00755872 Org: User:

Start: 11/30/07 End: 02/29/08 Due: 02/28/09

Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis

Phase: N/A Priority: Normal

NCT ID: NCT00619957 Org: User:

Start: 06/30/02 End: 05/31/07 Due: 05/31/08

Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women

Phase: N/A Priority: Normal

NCT ID: NCT00467259 Org: User:

Start: 04/30/07 End: 01/31/09 Due: 01/31/10

Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO

Phase: N/A Priority: Normal

NCT ID: NCT00577421 Org: User:

Start: 06/30/03 End: 01/31/06 Due: 01/31/07

Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure

Phase: N/A Priority: Normal

NCT ID: NCT00957034 Org: User:

Start: 07/31/09 End: 05/31/10 Due: 05/31/11

Treatment of Moderate to Severe Facial Acne Vulgaris

Phase: N/A Priority: Normal

NCT ID: NCT00612573 Org: User:

Start: 02/29/08 End: 12/31/08 Due: 12/31/09

Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)

Phase: N/A Priority: Normal

NCT ID: NCT00577473 Org: User:

Start: 02/28/01 End: 02/28/03 Due: 02/28/04

Safety, Pharmacokinetics, and Efficacy of 100, 150, and 200 mg Risedronate Administered to Women With Low BMD

Phase: N/A Priority: Normal

NCT ID: NCT00577837 Org: User:

Start: 04/30/04 End: 06/30/05 Due: 06/30/06

Treatment of Chlamydia Infection Comparing WC2031 Tablets With Vibramycin

Phase: N/A Priority: Normal

NCT ID: NCT01113931 Org: User:

Start: 04/30/10 End: 10/31/10 Due: 10/31/11

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream)	NCT01455597	Warner Chilcott	user2@example.com	None	2011-10-20	2012-12-03	2013-12-03	-	-	2025-07-14
Asacol Acute Diverticulitis(DIVA)Study	NCT00554099	Warner Chilcott	user2@example.com	None	2007-11-30	2010-03-31	2011-03-31	-	-	2025-07-14
Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido	NCT00349791	Warner Chilcott	user2@example.com	None	2002-06-30	2003-10-31	2004-10-31	-	-	2025-07-14
Effect of Udenafil on Spermatogenesis	NCT01230541	Warner Chilcott	user2@example.com	None	2010-09-30	2011-11-30	2012-11-30	-	-	2025-07-14
Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch	NCT00791856	Warner Chilcott	user2@example.com	None	2007-07-31	2008-05-31	2009-05-31	-	-	2025-07-14
Study Assessing Dosing Time and Calcium and Vitamin D on the Relative BA of 35 mg DR Risedronate Dosed With Food	NCT00868907	Warner Chilcott	user2@example.com	None	2009-03-31	2009-04-30	2010-04-30	-	-	2025-07-14
A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor Overactivity	NCT00712322	Warner Chilcott	user2@example.com	None	2008-10-07	2013-05-23	2014-05-23	-	-	2025-07-14
Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women	NCT01816139	Warner Chilcott	user2@example.com	None	2013-01-31	2013-11-19	2014-11-19	-	-	2025-07-14
Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia	NCT01845649	Warner Chilcott	user2@example.com	None	2013-04-12	2013-11-20	2014-11-20	-	-	2025-07-14
A Study to Assess the Bioequivalence of Different Formulations of Risedronate in Healthy Male and Female Subjects	NCT00846196	Warner Chilcott	user2@example.com	None	2009-01-31	2009-05-31	2010-05-31	-	-	2025-07-14
Fecal Biomarker Study for Patients With Ulcerative Colitis	NCT00780507	Warner Chilcott	user2@example.com	None	2007-08-31	2009-07-31	2010-07-31	-	-	2025-07-14
Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate	NCT00778154	Warner Chilcott	user2@example.com	None	2004-01-31	2006-12-31	2007-12-31	-	-	2025-07-14
Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate	NCT00635609	Warner Chilcott	user2@example.com	None	2008-03-31	2008-09-30	2009-09-30	-	-	2025-07-14
Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis	NCT01004185	Warner Chilcott	user2@example.com	None	2009-10-31	2011-03-31	2012-03-31	-	-	2025-07-14
A Study of Monthly Risedronate for Osteoporosis	NCT00247273	Warner Chilcott	user2@example.com	None	2005-10-31	2008-04-30	2009-04-30	-	-	2025-07-14
Study of Safety and Efficacy of an Oral Contraceptive	NCT00391807	Warner Chilcott	user2@example.com	None	2006-11-30	2008-09-30	2009-09-30	-	-	2025-07-14
Assess the Influence of a High-fat Meal on the Relative Bioavailability Of Two Formulations of Risedronate	NCT00755872	Warner Chilcott	user2@example.com	None	2007-11-30	2008-02-29	2009-02-28	-	-	2025-07-14
Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis	NCT00619957	Warner Chilcott	user2@example.com	None	2002-06-30	2007-05-31	2008-05-31	-	-	2025-07-14
Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women	NCT00467259	Warner Chilcott	user2@example.com	None	2007-04-30	2009-01-31	2010-01-31	-	-	2025-07-14
Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO	NCT00577421	Warner Chilcott	user2@example.com	None	2003-06-30	2006-01-31	2007-01-31	-	-	2025-07-14
Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure	NCT00957034	Warner Chilcott	user2@example.com	None	2009-07-31	2010-05-31	2011-05-31	-	-	2025-07-14
Treatment of Moderate to Severe Facial Acne Vulgaris	NCT00612573	Warner Chilcott	user2@example.com	None	2008-02-29	2008-12-31	2009-12-31	-	-	2025-07-14
Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)	NCT00577473	Warner Chilcott	user2@example.com	None	2001-02-28	2003-02-28	2004-02-28	-	-	2025-07-14
Safety, Pharmacokinetics, and Efficacy of 100, 150, and 200 mg Risedronate Administered to Women With Low BMD	NCT00577837	Warner Chilcott	user2@example.com	None	2004-04-30	2005-06-30	2006-06-30	-	-	2025-07-14
Treatment of Chlamydia Infection Comparing WC2031 Tablets With Vibramycin	NCT01113931	Warner Chilcott	user2@example.com	None	2010-04-30	2010-10-31	2011-10-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance